Polyrizon announces publication of patent application for hydrogel nasal tech

Polyrizon (PLRZ) announced the publication of a national phase patent application by the United States Patent and Trademark Office. The patent application encompasses key aspects of Polyrizon’s two core platform technologies: Capture and Contain, a nasal blocker technology, and Trap and Target, designed for advanced nasal drug delivery. The company said, “Polyrizon’s innovative Capture and Contain platform utilizes a natural 3D polymeric network engineered to adhere optimally to the nasal mucosa. This advanced network forms a physical barrier that captures and contains airborne biological threats, such as allergens, viruses, and molds, preventing their penetration and protecting the body. In addition, Polyrizon’s T&T platform is a novel drug delivery system designed for prolonged residence time and close contact with mucosal tissues, ensuring highly effective and targeted delivery of medications. Developed by drug delivery experts, the T&T platform can be customized to meet the unique requirements of different molecules, enhancing therapeutic efficacy and enabling a wide range of medical applications.”